Payer Network Scale Avalon serves over 30 health plans and 90 million members, demonstrating broad payer exposure and network reach that can be leveraged to cross-sell the Diagnostic Insights Platform and curated lab networks to additional payers and providers seeking optimized test utilization and timing.

Growth Capital Backing Recent investments from Francisco Partners and WindRose signal strong growth momentum and a commitment to scale tech-enabled payer services. Use the funding and strategic backing to accelerate go-to-market, expand product capabilities, and pursue larger enterprise deals with payers and providers.

Next Gen Platform The development of a next generation Diagnostic Insights Platform enables deeper data integration, real-time analytics, and evidence-based policies. Position Avalon as a data-driven partner for payers and health systems seeking ROI through waste reduction, faster adoption of diagnostics, and end-to-end workflow automation.

Market Credibility Awards and recognition as a USA TODAY Top Workplace and a Tampa Bay Top Workplace enhance credibility with risk-averse hospitals and payers. Leverage these accolades in RFPs, case studies, and reference calls to accelerate evaluations.

Diagnostics Upsell Avalon offers end-to-end diagnostics support including routine and genetic testing management and automated adherence, creating clear upsell opportunities for payers and providers aiming to optimize test panels, improve utilization, and streamline reimbursement workflows.